Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

Direct-Acting Antiviral's Impact on Patients' Adherence to HCV Drug Regimen

MAY 13, 2016 | CONTAGION EDITORIAL STAFF


Charitha Gowda, MD, MPH, infectious diseases physician at Penn Presbyterian Medical Center discusses the impact direct-acting antivirals have had on patients’ adherence to their drug regimen when treating hepatitis C.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.